AiScope is a Spanish-based startup with a mission to revolutionize infectious disease diagnosis using open-source technologies. The company's slogan - "We develop open-source technologies for an improved diagnosis of infectious diseases" perfectly encapsulates their vision to leverage technology for societal impact. By focusing on diseases like malaria, tuberculosis, and diarrhea, AiScope aims to address the pressing need for timely detection and treatment in low- and middle-income countries.
Founded in 2017, AiScope consists of a diverse team committed to leveraging AI and healthcare expertise to develop innovative solutions. Their flagship project, the AI Scope, is a non-profit, open-source smart microscope designed to enhance disease diagnosis using AI, particularly in resource-constrained and remote communities.
A distinctive aspect of AiScope is its emphasis on community involvement, as the company welcomes collaboration with individuals and organizations who share their passion for utilizing technology to improve public health. Although specific investment details are currently unavailable, AiScope's commitment to utilizing technological innovation for social good positions it as an intriguing prospect for potential investors seeking impactful opportunities.